Oral anticoagulant aspirin oral. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Plasma Blood Platelets

Organisms4

Sea Cucumbers Seaweed Phaeophyta Ancylostoma

Diseases46

Hemorrhage Thromboembolism Thrombophlebitis Venous Thromboembolism Atrial Fibrillation Thrombosis Venous Thrombosis Pulmonary Embolism Stroke Thrombophilia Blood Coagulation Disorders Postoperative Hemorrhage Hematoma Embolism Cerebral Hemorrhage Recurrence Intracranial Hemorrhages Antiphospholipid Syndrome Heart Diseases Graft Occlusion, Vascular Postoperative Complications Heart Valve Diseases Myocardial Infarction Brain Ischemia Acute Coronary Syndrome Activated Protein C Resistance Acute Disease Cardiovascular Diseases Protein C Deficiency Gastrointestinal Hemorrhage Protein S Deficiency Ischemia Antithrombin III Deficiency Lupus Erythematosus, Systemic Cerebrovascular Disorders Asthma, Aspirin-Induced Hypoprothrombinemias Hemorrhagic Disorders Intracranial Embolism and Thrombosis Abortion, Habitual Coagulation Protein Disorders Hematoma, Subdural Ischemic Attack, Transient Pregnancy Complications, Hematologic Disseminated Intravascular Coagulation Coronary Thrombosis

Chemicals and Drugs87

Anticoagulants Aspirin Acenocoumarol Warfarin beta-Alanine Phenindione Phenprocoumon Vitamin K Thiophenes Pyridones Antithrombins Factor Xa Benzimidazoles Platelet Aggregation Inhibitors Heparin, Low-Molecular-Weight Heparin Lupus Coagulation Inhibitor Prothrombin Protein C Blood Coagulation Factors Morpholines Fibrinolytic Agents Vitamin K Epoxide Reductases Coumarins Rodenticides Thrombin Dicumarol Factor X Enoxaparin Thromboplastin 4-Hydroxycoumarins Pyrazoles Coagulants Anti-Inflammatory Agents, Non-Steroidal Ticlopidine Protein S Azetidines Thrombomodulin Factor VII Amidines Fibrin Fibrinogen Degradation Products Antibodies, Antiphospholipid Antithrombin III Antibodies, Anticardiolipin Thromboxane B2 Pyridines Hirudins Salicylates Heparin Antagonists Mixed Function Oxygenases Cyclooxygenase Inhibitors Factor V beta 2-Glycoprotein I Pipecolic Acids Factor Va Aryl Hydrocarbon Hydroxylases Dermatan Sulfate Dalteparin Heparin Cofactor II Cardiolipins Sodium Salicylate Fibrin Polysaccharides Arthropod Proteins Dipyridamole Antithrombin Proteins Tablets, Enteric-Coated Factor VIIa Cyclooxygenase 1 Factor VIIIa Citric Acid Fibrinogen Prostaglandin-Endoperoxide Synthases Heparitin Sulfate Thromboxanes Heparinoids Citrates Ibuprofen Nadroparin Thromboxane A2 Phospholipids Hemostatics Recombinant Proteins Ancrod Chromogenic Compounds Cyclooxygenase 2 Inhibitors Glycoproteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment38

International Normalized Ratio Administration, Oral Prothrombin Time Blood Coagulation Tests Partial Thromboplastin Time Drug Monitoring Treatment Outcome Oral Surgical Procedures Thrombin Time Heart Valve Prosthesis Perioperative Care Randomized Controlled Trials as Topic Drug Therapy, Combination Risk Factors Pharmacovigilance Prospective Studies Drug Substitution Follow-Up Studies Clinical Trials as Topic Drug Administration Schedule Risk Assessment Clinical Trials, Phase III as Topic Thrombolytic Therapy Retrospective Studies Injections, Subcutaneous Platelet Function Tests Incidence Bleeding Time Vascular Surgical Procedures Tomography, X-Ray Computed Registries Double-Blind Method Whole Blood Coagulation Time Platelet Count Thrombelastography Blood Preservation Hirudin Therapy Blood Specimen Collection

Psychiatry and Psychology1

Medication Adherence

Phenomena and Processes16

Prothrombin Time Blood Coagulation Partial Thromboplastin Time Thrombin Time Time Factors Hemostasis Drug Interactions Dose-Response Relationship, Drug Platelet Aggregation Bleeding Time Platelet Activation Fibrinolysis Whole Blood Coagulation Time Drug Resistance Platelet Count Algorithms

Disciplines and Occupations1

Pharmacogenetics

Information Science4

Pharmacovigilance Incidence Registries Algorithms

Named Groups1

Health Care25

Treatment Outcome Perioperative Care Randomized Controlled Trials as Topic Risk Factors Pharmacovigilance Prospective Studies Drug Substitution Follow-Up Studies Clinical Trials as Topic Risk Assessment Clinical Trials, Phase III as Topic Point-of-Care Systems Retrospective Studies Practice Guidelines as Topic Drug Utilization Medication Adherence Incidence Rodent Control Guideline Adherence Age Factors Physician's Practice Patterns Cost-Benefit Analysis Registries Comorbidity Double-Blind Method

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Anticoagulants Aspirin Acenocoumarol Warfarin International Normalized Ratio beta-Alanine Administration, Oral Prothrombin Time Hemorrhage Thromboembolism Phenindione Phenprocoumon Vitamin K Thiophenes Pyridones Thrombophlebitis Antithrombins Blood Coagulation Factor Xa Blood Coagulation Tests Benzimidazoles Platelet Aggregation Inhibitors Venous Thromboembolism Atrial Fibrillation Heparin, Low-Molecular-Weight Thrombosis Heparin Lupus Coagulation Inhibitor Prothrombin Partial Thromboplastin Time Drug Monitoring Venous Thrombosis Protein C Blood Coagulation Factors Morpholines Pulmonary Embolism Fibrinolytic Agents Vitamin K Epoxide Reductases Stroke Coumarins Thrombophilia Blood Coagulation Disorders Treatment Outcome Rodenticides Thrombin Postoperative Hemorrhage Dicumarol Factor X Enoxaparin Thromboplastin Hematoma 4-Hydroxycoumarins Pyrazoles Oral Surgical Procedures Coagulants Embolism Thrombin Time Anti-Inflammatory Agents, Non-Steroidal Cerebral Hemorrhage Heart Valve Prosthesis Perioperative Care Randomized Controlled Trials as Topic Drug Therapy, Combination Ticlopidine Protein S Time Factors Risk Factors Azetidines Recurrence Hemostasis Drug Interactions Pharmacovigilance Thrombomodulin Intracranial Hemorrhages Prospective Studies Drug Substitution Dose-Response Relationship, Drug Antiphospholipid Syndrome Factor VII Follow-Up Studies Amidines Fibrin Fibrinogen Degradation Products Clinical Trials as Topic Drug Administration Schedule Pharmacogenetics Antibodies, Antiphospholipid Antithrombin III Risk Assessment Plasma Clinical Trials, Phase III as Topic Point-of-Care Systems Thrombolytic Therapy Antibodies, Anticardiolipin Platelet Aggregation Heart Diseases Retrospective Studies Graft Occlusion, Vascular Postoperative Complications Heart Valve Diseases Thromboxane B2

No FAQ available that match "oral anticoagulant aspirin oral"